Sana Stock 2025 . Sana) sana biotechnology currently has 223,268,889 outstanding shares. What is sana biotechnology's forecast for 2025?
(sana) stock price quote with breaking news, financials, statistics, charts and more. With sana biotechnology stock trading at $1.75 per share, the total value of sana.
Sana Stock 2025 Images References :
Source: www.alamy.com
Houthi supporters protest against the US and Israel in Sana a Houthi , Sana biotechnology inc stock (sana) is expected to reach an average price of $9.7538 in 2025, with a high prediction of $16.77 and a low estimate of $2.7384.
Source: www.alamy.com
Houthi supporters protest against the US and Israel in Sana a Houthi , Sana biotechs inselzelltherapie zeigt vielversprechende ergebnisse bei diabetes;
Source: www.alamy.com
Houthi supporters protest against the US and Israel in Sana a Houthi , Bofa lowered the firmโs price target on sana biotechnology (sana) to $7 from $8 and keeps a buy rating on the shares.
Source: www.youtube.com
Latest SANA News along with Price and Volume Analysis SANA Stock , Which shareholders are buying/selling shares of sana biotechnology (nasdaq:sana) stock?
Source: www.alamy.com
Houthi supporters protest against the US and Israel in Sana a Houthi , Detailed statistics for sana biotechnology, inc.
Source: www.alamy.com
Houthi supporters protest against the US and Israel in Sana a Houthi , Sana will host a webcast conference call to discuss results today, january 7, 2025 at 1:30 p.m.
Source: www.alamy.com
Houthi supporters protest against the US and Israel in Sana a Houthi , Sana), a company focused on changing the possible for patients through.
Source: www.alamy.com
Houthi supporters protest against the US and Israel in Sana a Houthi , Check out my analysis of sana stock.
Source: www.alamy.com
Houthi supporters protest against the US and Israel in Sana a Houthi , What is sana biotechnology, inc.'s (sana) stock forecast for 2025?
Source: www.alamy.com
Houthi supporters protest against the US and Israel in Sana a Houthi , When is sana biotechnology's next earnings announcement?